Prevalence of Human Metapneumovirus Infections in Iran: A Systematic Review and Meta-Analysis

Somayeh Shatizadeh Malekshahi1, Jila Yavarian2, Nazanin-Zahra Shafiei-Jandaghi2

  • 1Department of Virology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.

Insights

This study found human metapneumovirus (hMPV) has an intermediate prevalence in Iran, affecting 8.9% of the population, particularly children. Further research is needed to understand its distribution and genotypes across the country.

Area of Science:

  • Virology
  • Epidemiology
  • Public Health

Background:

  • Human metapneumovirus (hMPV) is an important respiratory pathogen.
  • Understanding hMPV prevalence in Iran is crucial for public health strategies.
  • Previous data on hMPV epidemiology in Iran is fragmented.

Purpose of the Study:

  • To systematically review and meta-analyze the prevalence of hMPV infections in Iran.
  • To consolidate existing epidemiological data on hMPV in the Iranian population.
  • To compare Iranian hMPV prevalence with global rates.

Main Methods:

  • Comprehensive literature search of multiple databases (PubMed, Scopus, Web of Science, etc.) and Persian national databases.
  • Inclusion of studies on hMPV epidemiology in Iran published up to June 2019.
  • Meta-analysis to estimate pooled prevalence rates and confidence intervals.

Main Results:

  • The overall estimated prevalence of hMPV in Iran was 8.9% (95% CI 5.4-14.2).
  • hMPV prevalence in Iran is intermediate compared to global estimates.
  • Pediatric populations showed a pooled prevalence of 7.6% (I² = 95%) for hMPV infections.

Conclusions:

  • This meta-analysis provides the first comprehensive overview of hMPV epidemiology in Iran over an 11-year period.
  • hMPV is circulating in Iran with a notable prevalence, especially in children.
  • Further large-scale epidemiological studies are recommended to assess prevalence and genotype distribution in understudied regions of Iran.

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.4K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
650
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.3K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.0K